The Market Devastation and Resurrection of Good Biotech Firms
Due to the market’s instability that we have been experiencing for a while now, we decided to look back at some biotech firms whose values tumbled and stocks tanked as a result of both internal and external bad circumstances and other reasons. The decision to retackle these firms is in our conviction that they will rebound and reach higher values than those we expected when their stocks were flying high. These biotech firms’ resurrection is new to us. Our latest  examples are Celldex Therapeutics (This content is for paid subscribers.